The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
a/k/a: CGD RT
199A Victoria Street
London, SW1E 5NE
The mission of the Chronic Granulomatous Disorder Society (CGD Society) is to be the leading source of support for individuals and families affected by chronic granulomatous disorder in the UK. They strive to achieve this by providing comprehensive and clearly written information on CGD and associated issues that is easily accessible through a variety of media; offering direct support to individuals and families affected by CGD through the provision of services and events; ensuring that essential financial assistance is available to support those affected by CGD in the UK; raising awareness and understanding of CGD within the medical profession in order to facilitate earlier diagnosis and promote increased understanding of the impacts of CGD on all medical disciplines, thereby extending and improving quality of life; supporting research that aims to identify better treatments and ultimately a cure for CGD, and the publication of the useful results of that research. Chronic granulomatous disease (CGD) is a rare inherited primary immune deficiency disorder that affects certain white blood corpuscles (neutrophils, monocytes, macrophages, eosinophils). The disorder is characterized by an inability to resist repeated infectious diseases and a tendency to develop chronic inflammation.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.